Podrobno

Modulating antibody N-glycosylation through feed additives using a multi-tiered approach
ID Kranjc, Jaka (Avtor), ID Kramer, Lovro (Avtor), ID Mikelj, Miha (Avtor), ID Anderluh, Marko (Avtor), ID Pišlar, Anja (Avtor), ID Brinc, Matjaž (Avtor)

URLURL - Izvorni URL, za dostop obiščite https://doi.org/10.3389/fbioe.2025.1517098 Povezava se odpre v novem oknu
URLURL - Izvorni URL, za dostop obiščite https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2024.1448925/full Povezava se odpre v novem oknu

Izvleček
Glycosylation of recombinant proteins is a post-translational modification that affects multiple physicochemical and biological properties of proteins. As such, it is a critical quality attribute that must be carefully controlled during protein production in the pharmaceutical industry. Glycosylation can be modulated by various conditions, including the composition of production media and feeds. In this study, the N-glycosylation-modulating effects of numerous compounds, including metal enzyme cofactors, enzyme inhibitors, and metabolic intermediates, were evaluated. Chinese hamster ovary cells producing three different IgG antibodies were cultivated in a fed-batch mode. First, a one-factor-at-a-time experiment was performed in 24-well deep well plates to identify the strongest modulators and appropriate concentration ranges. Then, a full response surface experiment was designed to gauge the effects and interactions of the 14 most effective hit compounds in an Ambr® 15 bioreactor system. A wide range of glycoform content was achieved, with an up to eight-fold increase in individual glycoforms compared to controls. The resulting model can be used to determine modulator combinations that will yield desired glycoforms in the final product.

Jezik:Angleški jezik
Ključne besede:bioprocess, glycosylation, modulators, modelling, Chinese hamster ovary, antibody production
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:FFA - Fakulteta za farmacijo
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2024
Št. strani:13 str.
Številčenje:Vol. 12, [article no.] 1448925
PID:20.500.12556/RUL-175589 Povezava se odpre v novem oknu
UDK:577.112
ISSN pri članku:2296-4185
DOI:10.3389/fbioe.2024.1448925 Povezava se odpre v novem oknu
COBISS.SI-ID:246929411 Povezava se odpre v novem oknu
Datum objave v RUL:05.11.2025
Število ogledov:86
Število prenosov:25
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Frontiers in bioengineering and biotechnology
Skrajšan naslov:Front. bioeng. biotechnol.
Založnik:Frontiers Editorial Office
ISSN:2296-4185
COBISS.SI-ID:523093017 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:bioprocesi, glikozilacija, modulatorji, modeliranje, jajčnik kitajskega hrčka, proizvodnja protiteles, rekombinantni protein

Projekti

Financer:Drugi - Drug financer ali več financerjev
Program financ.:Novartis Pharmaceutical Manufacturing LLC

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj